Stock Earnings

Question 1

Arcus Biosciences Inc'in temel mali tabloları nelerdir?

Accepted Answer

Son mali tabloya (Form-10K) göre, Arcus Biosciences Inc'in toplam varlıkları $1,150 olup, net loss $-283'dir.

Question 2

RCUS'ün temel finansal oranları nelerdir?

Accepted Answer

Arcus Biosciences Inc'in cari oranı 1.72, net kâr marjı -109.68, hisse başına satış $2.86'dir.

Question 3

Arcus Biosciences Inc'in geliri segment veya coğrafya bazında nasıl dağılıyor?

Accepted Answer

Arcus Biosciences Inc largest revenue segment is Immunotherapies, at a revenue of 258,000,000 in the most earnings release.For geography, United States is the primary market for Arcus Biosciences Inc, at a revenue of 258,000,000.

Question 4

Arcus Biosciences Inc kârlı mı?

Accepted Answer

no, son mali tablolara göre Arcus Biosciences Inc'in net loss $-283'dir.

Question 5

Arcus Biosciences Inc'in herhangi bir yükümlülüğü var mı?

Accepted Answer

yes, Arcus Biosciences Inc'in yükümlülüğü 665'dir.

Question 6

Arcus Biosciences Inc'in tedavüldeki hisse sayısı kaçtır?

Accepted Answer

Arcus Biosciences Inc'in toplam tedavüldeki hisse sayısı 92'dir.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	240	258	117	112	382	77
Revenue Growth (YoY)	-9%	121%	4%	-71%	396%	413%
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	112	120	117	104	72	42
Research & Development	503	448	340	288	256	159
Operating Expenses	615	568	457	392	328	201
Other Non Operating Income (Expenses)	-8	-4	-2	-2	0	--
Pretax Income	-340	-282	-301	-266	54	-122
Income Tax Expense	1	1	6	1	1	--
Net Income	-341	-283	-307	-267	52	-122
Net Income Growth	26%	-8%	15%	-613%	-143%	45%
Shares Outstanding (Diluted)	107	90	74	72	74	54.8
Shares Change (YoY)	18%	22%	3%	-3%	35%	25%
EPS (Diluted)	-3.18	-3.14	-4.15	-3.71	0.71	-2.24
EPS Growth	7%	-24%	12%	-623%	-132%	16%
Free Cash Flow	-464	-176	-330	432	-282	108
Free Cash Flow Per Share	-4.33	-1.95	-4.45	6	-3.81	1.97
Gross Margin	--	--	--	--	--	--
Operating Margin	-156.25%	-120.15%	-290.59%	-250%	14.13%	-161.03%
Profit Margin	-142.08%	-109.68%	-262.39%	-238.39%	13.61%	-158.44%
Free Cash Flow Margin	-193.33%	-68.21%	-282.05%	385.71%	-73.82%	140.25%
EBITDA	-365	-300	-332	-274	57	-121
EBITDA Margin	-152.08%	-116.27%	-283.76%	-244.64%	14.92%	-157.14%
D&A For EBITDA	10	10	8	6	3	3
EBIT	-375	-310	-340	-280	54	-124
EBIT Margin	-156.25%	-120.15%	-290.59%	-250%	14.13%	-161.03%
Effective Tax Rate	-0.29%	-0.35%	-1.99%	-0.37%	1.85%	--

Arcus Biosciences Inc (RCUS) Price

RCUS Stock Price Chart

RCUS Income

Follow-Up Questions